logo

Switching from a 2-dose to a 1-dose program of gender-neutral routine vaccination against human papillomavirus in Canada: a mathematical modelling analysis

November 2024

Drolet M, Laprise JF, Chamberland E, Sauvageau C, Wilson S, Lim GH, Ogilvie G, Tuite A, Brisson M.

CMAJ 2024;196(33):E1136-E1143